Potential role of ultra-sensitive estradiol assays in estimating the risk of breast cancer and fractures

[1]  R. Santen,et al.  Standardization of Steroid Hormone Assays: Why, How, and When? , 2007, Cancer Epidemiology Biomarkers & Prevention.

[2]  P. Goss,et al.  Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy , 2007, Steroids.

[3]  S. Cummings,et al.  Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. , 2007, Endocrine-related cancer.

[4]  S. Cummings,et al.  Comparison of methods to measure low serum estradiol levels in postmenopausal women. , 2006, The Journal of clinical endocrinology and metabolism.

[5]  R. Santen,et al.  Recombinant cell ultrasensitive bioassay for measurement of estrogens in postmenopausal women. , 2005, The Journal of clinical endocrinology and metabolism.

[6]  A. Hofman,et al.  Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam Study. , 2004, The Journal of clinical endocrinology and metabolism.

[7]  Ravinder J. Singh,et al.  Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. , 2004, Clinical chemistry.

[8]  S. Cummings,et al.  Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. , 1998, The New England journal of medicine.

[9]  J. Baron,et al.  Use of ultrasensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, letrozole. , 1995, The Journal of clinical endocrinology and metabolism.

[10]  J. Baron,et al.  Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. , 1994, The Journal of clinical investigation.

[11]  R. Santen,et al.  The efficacy of CGS 20267 in suppressing estrogen biosynthesis in patients with advanced stage breast cancer , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  R. Santen,et al.  Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. , 1978, The Journal of clinical endocrinology and metabolism.